The 4th General Assembly took place on 14–15 October 2025 in St-Blaise, Switzerland, hosted by our partner Alpes Lasers.
A true highlight of the meeting was the presentation by EMPA of the multi-pass gas cell prototype – a key optical component designed to maximise measurement precision in breath analysis. This innovation marks a significant milestone in the development of the VOCORDER device.
The meeting brought together all project partners to discuss crucial topics — from preparations for the upcoming 2nd project review to planning the next stages of clinical trials and system integration. Technical discussions focused on ensuring seamless collaboration between hardware, AI, and medical partners, creating solutions that bring the project closer to real-world impact.
💡The partners’ strong teamwork and commitment continue to drive VOCORDER forward — developing technology that one day enables early detection of diseases such as cancer through non-invasive breath analysis, improving lives and transforming healthcare.
